No Data
Simcere pharma (02096.HK) spent 5.12 million Hong Kong dollars to repurchase 0.756 million shares on November 19.
Gelonghui, November 19 - Simcere Pharma (02096.HK) announced that on November 19, it spent 5.12 million Hong Kong dollars to repurchase 0.756 million shares.
Zhijing Hong Kong Stocks Buyback Statistics | November 19th
Hong Kong stock repurchase statistics | November 19th
Simcere Pharma (02096.HK) spent 10.1667 million Hong Kong dollars on repurchasing 1.49 million shares on November 18th.
Globe News reported on November 18 that simcere pharma (02096.HK) announced it will spend 10.1667 million Hong Kong dollars to repurchase 1.49 million shares at a price ranging from 6.71 to 6.98 Hong Kong dollars per share.
Hong Kong stocks movement | Simcere pharma (02096) surged over 12% with trading volume exceeding 0.2 billion Hong Kong dollars. The company is expected to welcome multiple catalysts.
Simcere pharma (02096) surged over 12% in volume, as of the time of this report, it rose by 12.38%, priced at 6.99 Hong Kong dollars, with a trading volume of 0.233 billion Hong Kong dollars.
The new policy of prepayment of medical insurance fund has been released, and the pharmaceutical sector has ushered in a sharp rise. Experts believe it may be a way for medical institutions to release funding pressure.
On the 11th, the "Notice on Prepayment of Medical Insurance Fund" was issued, requiring the unified and improved basic medical insurance fund prepayment system at the national level. Experts believe that the prepayment system can effectively alleviate the problem of pharmaceutical industry debt, accelerate the turnover of funds for pharmaceutical companies. The medical sector showed a significant upward trend today, with listed companies attributing the rise to investor sentiment.
Multiple bullish factors boost pharmaceutical Hong Kong stocks. Institutions say they still face this risk in the short term.
①What are the policy measures to support the field of innovative drugs? ②What unfavorable effects on domestic pharmaceutical stocks might Trump's election bring about?
Simcere Pharmaceutical Group Limited's (HKG:2096) Business And Shares Still Trailing The MarketNo Data
No Data
